Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Andersohn

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|December 25, 2013
Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting databaseAntonios Douros, Elisabeth Bronder, Frank Andersohn, et al.
European Journal of Clinical Pharmacology|January 22, 2015
Erratum to: flupirtine-induced liver injury--seven cases from the Berlin Case-Control Surveillance Study and review of the German spontaneous adverse drug reaction reporting databaseAntonios Douros, Elisabeth Bronder, Frank Andersohn, et al.
European Journal of Clinical Pharmacology|November 8, 2014
Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance StudyMatthias Huber, Frank Andersohn, Giselle Sarganas, et al.
Clinical Drug Investigation|December 17, 2017
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKIHelen Mann, Frank Andersohn, Carolyn Bodnar, et al.
Pharmacoepidemiology and Drug Safety|May 26, 2017
Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopeniaJuliane Bolbrinker, Edeltraut Garbe, Antonios Douros, et al.
Pain and Therapy|April 29, 2017
Prevalence and Incidence Trends for Diagnosed Prescription Opioid Use Disorders in the United KingdomAndrew J M Cooper, Jenna Willis, Janice Fuller, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 10, 2021
Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database AnalysisHenri-Jean Aubin, Caroline Dureau-Pournin, Bruno Falissard, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 8, 2021
Corrigendum to: Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database AnalysisHenri-Jean Aubin, Caroline Dureau-Pournin, Bruno Falissard, et al.
European Journal of Clinical Pharmacology|December 22, 2011
Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance StudyEdeltraut Garbe, Frank Andersohn, Elisabeth Bronder, et al.
British Journal of Haematology|July 14, 2011
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance StudyEdeltraut Garbe, Frank Andersohn, Elisabeth Bronder, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|December 25, 2013
Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting databaseAntonios Douros, Elisabeth Bronder, Frank Andersohn, et al.
European Journal of Clinical Pharmacology|January 22, 2015
Erratum to: flupirtine-induced liver injury--seven cases from the Berlin Case-Control Surveillance Study and review of the German spontaneous adverse drug reaction reporting databaseAntonios Douros, Elisabeth Bronder, Frank Andersohn, et al.
European Journal of Clinical Pharmacology|November 8, 2014
Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance StudyMatthias Huber, Frank Andersohn, Giselle Sarganas, et al.
Clinical Drug Investigation|December 17, 2017
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKIHelen Mann, Frank Andersohn, Carolyn Bodnar, et al.
Pharmacoepidemiology and Drug Safety|May 26, 2017
Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopeniaJuliane Bolbrinker, Edeltraut Garbe, Antonios Douros, et al.
Pain and Therapy|April 29, 2017
Prevalence and Incidence Trends for Diagnosed Prescription Opioid Use Disorders in the United KingdomAndrew J M Cooper, Jenna Willis, Janice Fuller, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 10, 2021
Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database AnalysisHenri-Jean Aubin, Caroline Dureau-Pournin, Bruno Falissard, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 8, 2021
Corrigendum to: Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database AnalysisHenri-Jean Aubin, Caroline Dureau-Pournin, Bruno Falissard, et al.
European Journal of Clinical Pharmacology|December 22, 2011
Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance StudyEdeltraut Garbe, Frank Andersohn, Elisabeth Bronder, et al.
British Journal of Haematology|July 14, 2011
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance StudyEdeltraut Garbe, Frank Andersohn, Elisabeth Bronder, et al.
Pageof 6